Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit (LATA)

26. december 2019 opdateret af: University Hospital, Grenoble

Impact of a Written Document on Post Traumatic Stress Disorder (PTSD) Diagnosed in Family Members After Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit

Relatives of patients in situation of withholding and withdrawing life-sustaining therapies often show post traumatic stress disorder (PTSD) (60%)[1]. This number is even greater when family members are active in this decision (81%) or when communication is not optimal between medical team and family members.

There are several ways to assist families of patients in intensive care units [2], amongst them the use of a written document to explain the environment, therapies and possible outcomes.

Here the investigators want to test the impact of a written document in the context of end-of-life conference in intensive care units. Specifically, this research addresses wether such written support could decrease 3-months post-traumatic stress disorder, anxiety and depression exhibited by the closest family member or the patient representative.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

74

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Grenoble, Frankrig, 38043
        • Anesthesiology and Critical Care Depratment, Grenoble University Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

The study will enroll patient representant (family member or close friends designed by the family or pre-admission legal representant).

Inclusion Criteria:

  • Medical team anticipates a decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
  • verbal consent to participate
  • Able to communicate in French

Exclusion Criteria:

  • representant of a patient < 18 years old
  • representant of a patient whose stay in ICU lasted less than 48 hours
  • representant of a patient without social security

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Written document
Accompanying relatives with a written document when discussing withholding and withdrawing life-sustaining therapies . All other procedures are standard.
The document describes the law and the role of family members and medical team in the decision.
Aktiv komparator: Standard
Discussing withholding and withdrawing life-sustaining therapies following standard procedure without written document

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Rate of PTSD
Tidsramme: 3 months
PTSD is assessed with Impact Event Scale (IES) on the family representative
3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Rate of depression
Tidsramme: 3 months
Depression is assessed with Hospital Anxiety and Depression scale (HADS) on the family representative
3 months
Rate of anxiety
Tidsramme: 3 months
Anxiety is assessed with Hospital Anxiety and Depression scale (HADS) on the family representative
3 months
Mean level of HADS (anxiety and depression subscales)
Tidsramme: 3 months
3 months
Mean level of IES
Tidsramme: 3 months
3 months
Length of the processus from decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
Tidsramme: An average of 6 days
An average of 6 days
Respectfulness of the law regarding withholding and withdrawing life-sustaining therapies
Tidsramme: An average of 6 days
An average of 6 days
Rate of decision to withhold and withdraw life-sustaining therapies in different intensive care units from the hospital
Tidsramme: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)
Medical Doctor satisfaction with the processus
Tidsramme: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)
Description of the processus
Tidsramme: ICU discharge (an average of 3 weeks)
ICU discharge (an average of 3 weeks)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. september 2014

Primær færdiggørelse (Faktiske)

1. oktober 2017

Studieafslutning (Faktiske)

1. marts 2018

Datoer for studieregistrering

Først indsendt

29. december 2014

Først indsendt, der opfyldte QC-kriterier

29. december 2014

Først opslået (Skøn)

31. december 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

27. december 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

26. december 2019

Sidst verificeret

1. december 2019

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2014-A00758-39

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner